0001179110-18-006906.txt : 20180516 0001179110-18-006906.hdr.sgml : 20180516 20180516173020 ACCESSION NUMBER: 0001179110-18-006906 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180514 FILED AS OF DATE: 20180516 DATE AS OF CHANGE: 20180516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dreier Ashley CENTRAL INDEX KEY: 0001614957 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36568 FILM NUMBER: 18841015 MAIL ADDRESS: STREET 1: 15 W. SCENIC POINTE DR., STE. 100 CITY: DRAPER STATE: UT ZIP: 84020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHEQUITY INC CENTRAL INDEX KEY: 0001428336 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 BUSINESS PHONE: 801-727-1000 MAIL ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84020 4 1 edgar.xml FORM 4 - X0306 4 2018-05-14 0 0001428336 HEALTHEQUITY INC HQY 0001614957 Dreier Ashley C/O HEALTHEQUITY, INC. 15 W. SCENIC POINTE DR., STE. 100 DRAPER UT 84020 0 1 0 0 Executive, VP, CTO and CIO Common Stock 2018-05-14 4 M 0 16750 1.50 A 49939 D Common Stock 2018-05-14 4 M 0 3000 14.00 A 52939 D Common Stock 2018-05-14 4 M 0 16250 24.36 A 69189 D Common Stock 2018-05-14 4 S 0 32300 70.8475 D 36889 D Common Stock 2018-05-14 4 S 0 3700 71.7676 D 33189 D Stock Option (right to buy) 1.50 2018-05-14 4 M 0 16750 0 D 2023-05-09 Common Stock 16750 0 D Stock Option (right to buy) 14 2018-05-14 4 M 0 3000 0 D 2024-07-30 Common Stock 3000 0 D Stock Option (right to buy) 24.36 2018-05-14 4 M 0 16250 0 D 2026-03-23 Common Stock 16250 32500 D The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2017, as amended on April 12, 2018. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.36 to $71.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.38 to $72.24, inclusive. The option is immediately exercisable. The option becomes exercisable as to 32,500 shares in two equal installments on March 23, 2019 and 2020. /s/ Ashley Dreier 2018-05-15